Related Experiment Video
Updated: Feb 17, 2026
09:57
Isolation and Analysis of Traceable and Functionalized Extracellular Vesicles from the Plasma and Solid Tissues
Published on: October 17, 2022
2.8K
Extracellular vesicles in leukemia
Alejandro Pando1, John L Reagan1, Peter Quesenberry1
1Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Leukemia Research
|December 1, 2017
Summary
Leukemia extracellular vesicles (EVs) drive cancer progression and treatment evasion by altering the cellular microenvironment. These EVs offer potential for novel diagnostic and therapeutic strategies in leukemia treatment.
Area of Science:
- Biomedical Sciences
- Oncology
- Cell Biology
Background:
- Extracellular vesicles (EVs) are key mediators of intercellular communication, carrying molecular cargo from parent cells.
- Leukemia-derived EVs significantly influence tumor progression and contribute to therapeutic resistance.
- Understanding leukemia EVs is crucial for developing effective cancer treatments.
Purpose of the Study:
- To review the role of EVs in leukemia.
- To explore how leukemia EVs modulate the tumor microenvironment, hematopoiesis, and immune responses.
- To discuss current and future EV-based therapeutic applications in leukemia.
Main Methods:
- Literature review of studies on extracellular vesicles in leukemia.
- Analysis of the mechanisms by which leukemia EVs impact the tumor microenvironment.
- Examination of the potential of EVs as diagnostic markers and therapeutic agents.
Main Results:
- Leukemia EVs promote a pro-cancerous microenvironment through cell-to-cell communication.
- EVs contribute to immune evasion and altered hematopoiesis in leukemia.
- The cargo of leukemia EVs influences various cellular processes, facilitating malignancy.
Conclusions:
- Leukemia EVs play a multifaceted role in promoting cancer progression and immune evasion.
- EVs represent promising candidates for developing novel diagnostic and therapeutic strategies for leukemia.
- Further research into EV biology is essential for advancing leukemia treatment.
Related Concept Videos
01:36Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
01:38Intralumenal Vesicles and Multivesicular Bodies
4.9K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.9K